Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update

K. Devaraja, Sadhna Aggarwal, Sumit Singh Verma, Subash Chandra Gupta

Research output: Contribution to journalReview article

Abstract

Aims: The current article provides a detailed account of the current understanding of molecular and clinico-pathological aspects of Human papilloma virus (HPV) driven head and neck squamous cell carcinoma (HNSCC). Materials and methods: The literature review included most of the landmark trials and clinical studies related to the HPV driven HNSCC. Key findings: HPV positive HNSCC differ distinctly from HPV negative tobacco-related HNSCC, especially in oropharyngeal region. Therefore, the American joint committee on cancer`s latest manual for classification and staging of cancer suggests a separate staging system for HPV positive oropharyngeal cancers. Despite the younger patients being affected and the high propensity for cervical metastasis, the HPV positive oropharyngeal cancers respond much better to the treatment. The association with wild type TP53 and low EGFR expression confers the favorable prognosis in HPV driven HNSCC. Since the association is not universal, we suggest checking for p53 and EGFR expression status before considering de-intensification of therapy. In addition, the presence of matted lymph nodes and five or more nodes could mean relatively poorer prognosis, and are not suitable for de-intensification of therapy. The same is also true probably with higher T stage and co-existing tobacco use. The methods for the detection of p16, HPV DNA, HPV E6/E7 mRNA, anti-E6/E7 antibodies, in tissue, in serum and in saliva of patients, along with their clinical implications are also discussed. Significance: This article provides latest developments on the HPV driven HNSCC. ‘Diagnosis of transcriptionally active HPV infection,’ ‘Modalities for surveillance,’ ‘Implication of de-escalation of therapy’ are some of the critical issues that could serve the medical, the research as well as the patient communities.

Original languageEnglish
Article number117383
JournalLife Sciences
Volume245
DOIs
Publication statusPublished - 15-03-2020

Fingerprint

Papillomaviridae
Viruses
Oropharyngeal Neoplasms
Tobacco
Carcinoma, squamous cell of head and neck
Epithelial Cells
Neoplasm Staging
Tobacco Use

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{89f8f045fb9f4dfc881693e59a57d9e8,
title = "Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update",
abstract = "Aims: The current article provides a detailed account of the current understanding of molecular and clinico-pathological aspects of Human papilloma virus (HPV) driven head and neck squamous cell carcinoma (HNSCC). Materials and methods: The literature review included most of the landmark trials and clinical studies related to the HPV driven HNSCC. Key findings: HPV positive HNSCC differ distinctly from HPV negative tobacco-related HNSCC, especially in oropharyngeal region. Therefore, the American joint committee on cancer`s latest manual for classification and staging of cancer suggests a separate staging system for HPV positive oropharyngeal cancers. Despite the younger patients being affected and the high propensity for cervical metastasis, the HPV positive oropharyngeal cancers respond much better to the treatment. The association with wild type TP53 and low EGFR expression confers the favorable prognosis in HPV driven HNSCC. Since the association is not universal, we suggest checking for p53 and EGFR expression status before considering de-intensification of therapy. In addition, the presence of matted lymph nodes and five or more nodes could mean relatively poorer prognosis, and are not suitable for de-intensification of therapy. The same is also true probably with higher T stage and co-existing tobacco use. The methods for the detection of p16, HPV DNA, HPV E6/E7 mRNA, anti-E6/E7 antibodies, in tissue, in serum and in saliva of patients, along with their clinical implications are also discussed. Significance: This article provides latest developments on the HPV driven HNSCC. ‘Diagnosis of transcriptionally active HPV infection,’ ‘Modalities for surveillance,’ ‘Implication of de-escalation of therapy’ are some of the critical issues that could serve the medical, the research as well as the patient communities.",
author = "K. Devaraja and Sadhna Aggarwal and Verma, {Sumit Singh} and Gupta, {Subash Chandra}",
year = "2020",
month = "3",
day = "15",
doi = "10.1016/j.lfs.2020.117383",
language = "English",
volume = "245",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",

}

Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma : A comprehensive update. / Devaraja, K.; Aggarwal, Sadhna; Verma, Sumit Singh; Gupta, Subash Chandra.

In: Life Sciences, Vol. 245, 117383, 15.03.2020.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma

T2 - A comprehensive update

AU - Devaraja, K.

AU - Aggarwal, Sadhna

AU - Verma, Sumit Singh

AU - Gupta, Subash Chandra

PY - 2020/3/15

Y1 - 2020/3/15

N2 - Aims: The current article provides a detailed account of the current understanding of molecular and clinico-pathological aspects of Human papilloma virus (HPV) driven head and neck squamous cell carcinoma (HNSCC). Materials and methods: The literature review included most of the landmark trials and clinical studies related to the HPV driven HNSCC. Key findings: HPV positive HNSCC differ distinctly from HPV negative tobacco-related HNSCC, especially in oropharyngeal region. Therefore, the American joint committee on cancer`s latest manual for classification and staging of cancer suggests a separate staging system for HPV positive oropharyngeal cancers. Despite the younger patients being affected and the high propensity for cervical metastasis, the HPV positive oropharyngeal cancers respond much better to the treatment. The association with wild type TP53 and low EGFR expression confers the favorable prognosis in HPV driven HNSCC. Since the association is not universal, we suggest checking for p53 and EGFR expression status before considering de-intensification of therapy. In addition, the presence of matted lymph nodes and five or more nodes could mean relatively poorer prognosis, and are not suitable for de-intensification of therapy. The same is also true probably with higher T stage and co-existing tobacco use. The methods for the detection of p16, HPV DNA, HPV E6/E7 mRNA, anti-E6/E7 antibodies, in tissue, in serum and in saliva of patients, along with their clinical implications are also discussed. Significance: This article provides latest developments on the HPV driven HNSCC. ‘Diagnosis of transcriptionally active HPV infection,’ ‘Modalities for surveillance,’ ‘Implication of de-escalation of therapy’ are some of the critical issues that could serve the medical, the research as well as the patient communities.

AB - Aims: The current article provides a detailed account of the current understanding of molecular and clinico-pathological aspects of Human papilloma virus (HPV) driven head and neck squamous cell carcinoma (HNSCC). Materials and methods: The literature review included most of the landmark trials and clinical studies related to the HPV driven HNSCC. Key findings: HPV positive HNSCC differ distinctly from HPV negative tobacco-related HNSCC, especially in oropharyngeal region. Therefore, the American joint committee on cancer`s latest manual for classification and staging of cancer suggests a separate staging system for HPV positive oropharyngeal cancers. Despite the younger patients being affected and the high propensity for cervical metastasis, the HPV positive oropharyngeal cancers respond much better to the treatment. The association with wild type TP53 and low EGFR expression confers the favorable prognosis in HPV driven HNSCC. Since the association is not universal, we suggest checking for p53 and EGFR expression status before considering de-intensification of therapy. In addition, the presence of matted lymph nodes and five or more nodes could mean relatively poorer prognosis, and are not suitable for de-intensification of therapy. The same is also true probably with higher T stage and co-existing tobacco use. The methods for the detection of p16, HPV DNA, HPV E6/E7 mRNA, anti-E6/E7 antibodies, in tissue, in serum and in saliva of patients, along with their clinical implications are also discussed. Significance: This article provides latest developments on the HPV driven HNSCC. ‘Diagnosis of transcriptionally active HPV infection,’ ‘Modalities for surveillance,’ ‘Implication of de-escalation of therapy’ are some of the critical issues that could serve the medical, the research as well as the patient communities.

UR - http://www.scopus.com/inward/record.url?scp=85078897361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078897361&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2020.117383

DO - 10.1016/j.lfs.2020.117383

M3 - Review article

C2 - 32007572

AN - SCOPUS:85078897361

VL - 245

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

M1 - 117383

ER -